| |
2011 |
2012 |
2013 |
2014 |
Overall |
| Positive Marker |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
| HBc-Ab |
223 |
7.2 |
357 |
6.2 |
397 |
5.7 |
408 |
5.7 |
1385 |
6 |
| HBc-Ab+HbsAg+HBV-DNA |
18 |
0.6 |
39 |
0.7 |
40 |
0.6 |
44 |
0.61 |
141 |
0.61 |
| HBsAg |
2 |
0.06 |
8 |
0.1 |
3 |
0.04 |
0 |
0.01 |
13 |
0.05 |
| HBc-Ab+HBV-DNA |
3 |
0.1 |
4 |
0.07 |
1 |
0.01 |
2 |
0.03 |
10 |
0.04 |
| HBV-DNA |
0 |
0 |
4 |
0.07 |
2 |
0.03 |
4 |
0.06 |
10 |
0.04 |
| HBc-Ab+HBV-DNA+HCV-RNA |
0 |
0 |
0 |
0 |
3 |
0.04 |
0 |
0 |
3 |
0.01 |
| Anti-HCV |
6 |
0.2 |
21 |
0.4 |
39 |
0.6 |
28 |
0.4 |
94 |
0.41 |
| Anti-HCV+HCV-RNA |
0 |
0 |
2 |
0.04 |
4 |
0.06 |
2 |
0.03 |
8 |
0.04 |
| Anti-HIV |
3 |
0.1 |
1 |
0.02 |
3 |
0.04 |
3 |
0.04 |
10 |
0.04 |
| Anti-HIV+HIV RNA |
0 |
0 |
1 |
0.02 |
4 |
0.06 |
1 |
0.01 |
6 |
0.03 |
| Trend in numbers and prevalence of combined HBV, HCV, and HIV serological and nucleic acid profiles among blood donors in Makkah from 2011 to 2014. |
|
